The 2nd International Conference on Drug Discovery & Therapy: Dubai, February 1 - 4, 2010

Poster Presenter

Design, Synthesis and Anti-Influenza Activity of Artificial Ribonucleases
Koroleva L.S., Burakova E.A., Lozitsky V.P., Fedchuk A.S., Silnikov V.N.
Russia

The synthesis of molecules that are capable of nonrandom RNA cleavage has found a variety of important applications. Such molecules are used in rational design of novel antiviral, since RNA is the genetic material of many pathogenic viruses. We have designed and synthesized artificial ribonucleases (artRNases) based on short peptides mimicking of RNAse T1 catalytic center. Ability of artificial RNases to RNA cleavage was shown in experiments with 96-mer RNA HIV-1. Anti-influenza activity in vitro of 15 such artRNases was investigated by inhibition of reproduction virus A/Hong Kong/1/68 (H3N2) in tissue cultures of chorioallantoic membranes (CCM) of 12-14 days age chick embryos. Samples of compounds under examination were dissolved in special medium to 10-3 M concentration. CCM were infected with 1000 TID50 (tissue infection dose) of influenza virus. Studied synthetic RNases were divided on 4 groups: 1) - tetrapeptides bearing lipophobic fragment; 2) - polycationic structures containing an aromatic framework with two residues of bis-quaternary salts of 1,4-diazabicyclo[2.2.2]octane (Dp12, Dm4, D5-12); 3) - peptide-like molecules containing hydrophilic linker within molecule (K-L1-K, S-L1-S, R-L1-R, pep1-L1-pep1, pep2-L1-pep2, pep3-L1-pep3); 4) - peptide-like molecules containing hydrophobic linker within molecule (E-L2-E, K-L2-K, S-L2-S and EBzl-L2-EBzl). In 1st group compound EGKG-OAlk decreased virus amount on 1.0 log10 TID50. In 2nd group compound D5-12 inhibited replication of influenza virus on 5,4 log10 TID50. In 3rd group peptides pep1-L1-pep1, S-L1-S and R-L1-R exhibited antiviral activity from 1,75 to till 2.75 log10 TID50 and compounds K-L1-K and pep3-L1-pep3 decreased virus amount on 3.9 and 4.3 log10 TID50 respectively. In 4th group compounds E-L2-E and K-L2-K inhibited replication of influenza virus from 2.0 till 3.04 log10 TID50. Antiviral activity of compounds EBzl-L2-EBzl and S-L2-S was more than 5.0 log10 TID50.

The research is supported by integration grant #88 from Siberian Branch of Russian Academy of Sciences and RFBR grants #09-04-01483, 07-04-00990-a, 08-04-90038-Bel_a














[Webmaster]   Copyright © 2010 2nd International Conference on Drug Design & Therapy